Physician
Leitchfield Pediatric Clinic P.S.C.
Leitchfield Pediatric Clinic P.S.C. was paid $9.01M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.
33Billing provider infoLEITCHFIELD PEDIATRIC CLINIC P.S.C.
LEITCHFIELD, KY 42754
LEITCHFIELD, KY 42754
33aNPI1558318543assigned 05/27/2006
33bProvider typePediatrics Physician
28Total paid$9.01M
24GClaims362,153
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Kentucky
Rank by total paid#2 of 156
Median peer was paid$41K
This provider vs. median219×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 54,626 | $1.10M | |
| 2019 | 59,038 | $1.53M | |
| 2020 | 51,490 | $1.19M | |
| 2021 | 55,325 | $1.40M | |
| 2022 | 55,676 | $1.52M | |
| 2023 | 48,042 | $1.25M | |
| 2024incomplete | 37,956 | $1.03M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 59,769 | 53,412 | $2.05M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 26,029 | 23,919 | $1.49M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.0% | 11,020 | 10,622 | $722K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.9% | 28,543 | 22,021 | $711K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 7.3% | 23,201 | 21,015 | $658K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.5% | 9,657 | 9,221 | $582K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6.2% | 6,548 | 5,784 | $555K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.4% | 7,537 | 7,313 | $488K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.3% | 8,771 | 8,366 | $388K |
| 90461 | 3.5% | 12,013 | 11,255 | $315K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.3% | 2,896 | 2,793 | $208K |
| 96160 | 1.4% | 41,459 | 31,764 | $129K |
80 more codes
| H0049 | Alcohol and/or drug screening | <1% | 3,337 | $67K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,283 | $61K |
| 95117 | <1% | 4,697 | $57K | |
| 96127 | <1% | 15,405 | $55K | |
| 99429 | <1% | 629 | $45K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,220 | $40K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,141 | $33K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,140 | $33K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,227 | $29K |
| 99408 | <1% | 742 | $27K | |
| 99188 | <1% | 1,718 | $24K | |
| 96161 | <1% | 7,085 | $19K | |
| 90686 | <1% | 9,802 | $18K | |
| 92551 | <1% | 1,839 | $18K | |
| 92583 | <1% | 796 | $17K | |
| 80061 | Lipid panel | <1% | 1,316 | $16K |
| 90670 | <1% | 5,574 | $15K | |
| 36416 | <1% | 10,488 | $13K | |
| 99051 | <1% | 7,485 | $10K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 674 | $10K |
| 94760 | <1% | 5,632 | $9K | |
| 83655 | <1% | 766 | $9K | |
| 0072A | <1% | 245 | $8K | |
| 90723 | <1% | 3,646 | $7K | |
| 0002A | <1% | 217 | $7K | |
| 0001A | <1% | 201 | $6K | |
| 82948 | <1% | 1,295 | $6K | |
| 99173 | <1% | 129 | $5K | |
| 90647 | <1% | 3,327 | $5K | |
| 80305 | <1% | 466 | $5K | |
| 0071A | <1% | 167 | $5K | |
| 90480 | <1% | 122 | $4K | |
| 99174 | <1% | 202 | $4K | |
| 90633 | <1% | 1,147 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 64 | $3K |
| 81003 | <1% | 1,454 | $3K | |
| 90681 | <1% | 832 | $2K | |
| 90651 | <1% | 304 | $2K | |
| 90685 | <1% | 266 | $2K | |
| 99462 | <1% | 78 | $2K | |
| 99460 | <1% | 40 | $2K | |
| 97803 | <1% | 168 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 157 | $2K |
| D1206 | Topical application of fluoride varnish | <1% | 100 | $1K |
| 90677 | <1% | 505 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 57 | $910.92 |
| 0004A | <1% | 27 | $880.00 | |
| 0082A | <1% | 45 | $867.20 | |
| 90656 | <1% | 526 | $843.80 | |
| 0074A | <1% | 29 | $830.00 | |
| 98960 | <1% | 27 | $539.98 | |
| 97802 | <1% | 66 | $486.67 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 31 | $401.80 |
| 82947 | <1% | 113 | $347.66 | |
| 69210 | <1% | 15 | $342.06 | |
| 99000 | <1% | 3,229 | $338.92 | |
| 0081A | <1% | 18 | $280.00 | |
| 82436 | <1% | 42 | $236.67 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 18 | $203.70 |
| 90734 | <1% | 127 | $202.40 | |
| 94761 | <1% | 52 | $167.58 | |
| 91321 | <1% | 16 | $145.92 | |
| 90707 | <1% | 31 | $128.80 | |
| 90715 | <1% | 12 | $115.88 | |
| 91319 | <1% | 19 | $87.78 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 82 | $63.18 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 133 | $24.65 |
| 36415 | Collection of venous blood by venipuncture | <1% | 13 | $22.90 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 147 | $14.93 |
| 3008F | 0% | 8,146 | $0.00 | |
| 91307 | 0% | 538 | $0.00 | |
| 90716 | 0% | 61 | $0.00 | |
| 90696 | 0% | 29 | $0.00 | |
| 91318 | 0% | 16 | $0.00 | |
| 90620 | 0% | 13 | $0.00 | |
| 2014F | 0% | 3,137 | $0.00 | |
| 90710 | 0% | 29 | $0.00 | |
| 91300 | 0% | 557 | $0.00 | |
| 91308 | 0% | 164 | $0.00 | |
| 90700 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROBINSON, LYNN (CREDITIALING)